- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy potentially undervalued
Chinese Pharmaceuticals & Biotech Healthy potentially undervalued
Results
16
Companies which are potentially undervalued and in an acceptable financial position.
16 companies
Tasly Pharmaceutical Group
Market Cap: CN¥21.0b
Engages in the research, development, production, and sale of pharmaceuticals in China.
600535
CN¥14.14
7D
-2.0%
1Y
-11.2%
Shanghai Fosun Pharmaceutical (Group)
Market Cap: CN¥57.1b
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
CN¥23.17
7D
-4.2%
1Y
-1.9%
Yunnan Baiyao GroupLtd
Market Cap: CN¥88.3b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥48.85
7D
-4.0%
1Y
-13.0%
Dong-E-E-Jiao
Market Cap: CN¥31.0b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥48.39
7D
-4.7%
1Y
-12.6%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥13.3b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥8.27
7D
-3.0%
1Y
-24.4%
Amoy Diagnostics
Market Cap: CN¥7.2b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥18.42
7D
-5.3%
1Y
-8.6%
WuXi AppTec
Market Cap: CN¥311.2b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥104.11
7D
2.3%
1Y
67.4%
Pharmaron Beijing
Market Cap: CN¥43.7b
Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.
300759
CN¥25.50
7D
-3.2%
1Y
11.1%
Tianjin Ringpu Bio-TechnologyLtd
Market Cap: CN¥7.4b
Engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products.
300119
CN¥16.10
7D
-6.2%
1Y
-37.9%
Livzon Pharmaceutical Group
Market Cap: CN¥25.2b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.
000513
CN¥30.73
7D
-1.4%
1Y
-14.9%
Shenzhen Kangtai Biological Products
Market Cap: CN¥15.1b
Engages in the research, development, production, and sale of human vaccines in China and internationally.
300601
CN¥13.19
7D
-6.6%
1Y
-5.2%
AcrobiosystemsLtd
Market Cap: CN¥7.1b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥41.60
7D
-6.0%
1Y
14.4%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥40.6b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥24.21
7D
-2.9%
1Y
-25.1%
Jiangsu Hengrui PharmaceuticalsLtd
Market Cap: CN¥328.3b
A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.
600276
CN¥49.20
7D
-4.6%
1Y
-7.9%
Chongqing Zhifei Biological Products
Market Cap: CN¥32.8b
A biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China.
300122
CN¥13.38
7D
-10.4%
1Y
-30.6%
Beijing Tongrentang
Market Cap: CN¥34.6b
Engages in the production and sale of traditional Chinese medicine preparations in China and internationally.
600085
CN¥25.23
7D
-3.4%
1Y
-33.3%